Fri.Nov 29, 2019

Today’s Answer of the Day

TheAnswerPage

Excluding potential drug:drug interactions, what adverse effects of CBD have been noted in clinical trials? In clinical trials evaluating CBD, adverse effects, including diarrhea, somnolence, decreased appetite, change in weight, and increased levels of liver enzymes have been noted.

UK Firm Mackrell Upgrades Cannabis Team

Cannabis Law Report

Here’s the press release. Cannabis Law News

Trending Sources

How CBD:THC Blends Work: Half Baked – Exploring the Biases of NAM

Cannabis Life Network

CBD has become a global phenomenon, whether as a medicine or just a dietary supplement. In reality, a lot of therapeutic effects that people are buying into are really just placebo effects. With that being said, CBD does heal and help with many conditions, especially epilepsy.

THC 52

Singapore Stands Fast On Cannabis Liberalization

Cannabis Law Report

Grizzle report… A senior member of the Singapore government has voiced concern about the increasingly liberal approach to cannabis that various countries have adopted.

Quebec’s Couche Tard convenience plans to bid on Cannabis NB

Leafly

The retail chain with assets including Circle K and Mac’s Milk convenience stores, has been eager to get into legal cannabis retail for years. The post Quebec’s Couche Tard convenience plans to bid on Cannabis NB appeared first on Leafly. Canada Industry New Brunswick retail retail stores

European Medicinal Cannabis Association (EUMCA) Say Germany Has The Cannabis Model The EU Should Adopt

Cannabis Law Report

Euractiv report… Germany’s regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA).

More Trending

New York Times: Wave of European Cannabis Firms to List in 2020, Analyst Says

Cannabis Law Report

LONDON — Up to five companies active in the cannabis industry could go public in 2020 in Europe, a continent whose stock markets have largely missed out on the North-American “pot stocks” frenzy, a leading industry analyst said on Thursday.

Hemp 52

The FDA Issues Hemp-CBD Warning Letters and a Consumer Update

Canna Law Blog

The Food and Drug Administration (“FDA”) had a busy Monday this week. On November 25, the agency issued warning letters to 15 businesses selling hemp-derived CBD (“Hemp-CBD”) products as unapproved drugs. The FDA also released updated consumer guidance on Hemp-CBD. Warning Letters.

Data 52

Weed and mental health – everything you should know

Cannabis Law Report

The cannabis plant contains more than 500 identified chemical constituents. More than 100 of them are cannabinoids. Medical marijuana uses the cannabis plant or its basic chemicals to treat a whole bunch of different diseases and conditions.